CNTB - Company ID 0001835268
Connect Biopharma Holdings Ltd trades as CNTB. In its fiscal 2025 annual report the company posted revenue of $64.00K, down 99.8% from the prior year and net income of -$55.48M. This page tracks Connect Biopharma Holdings Ltd through 180 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| F-3 | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| Major company event | 8-K | 2026-04-23 |
| SCHEDULE 13G | - | 2026-04-14 |
| Insider trade | 4 | 2026-04-02 |
| Insider trade | 4 | 2026-04-02 |
The largest companies sharing Connect Biopharma Holdings Ltd's SEC industry classification (pharmaceutical preparations).
Connect Biopharma Holdings Ltd reported revenue of $64.00K for fiscal year 2025, a decrease of 99.8% year over year.
In its latest fiscal year Connect Biopharma Holdings Ltd reported a net loss of $55.48M.